Skip to main content
Clinical Trials/ACTRN12616001082493
ACTRN12616001082493
Active, Not Recruiting
N/A

Effectiveness of customised pre-formed foot orthoses in reducing lower limb pain, swollen and tender joints, and in improving quality of life and gait parameters in children with juvenile idiopathic arthritis: a randomised control trial.

The University of Newcastle0 sites66 target enrollmentAugust 11, 2016

Overview

Phase
N/A
Intervention
Not specified
Conditions
Juvenile Idiopathic Arthritis
Sponsor
The University of Newcastle
Enrollment
66
Status
Active, Not Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 11, 2016
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Diagnosed with JIA according to ILAR (International League of Associations for Rheumatology) criteria.
  • 2\. Age 5 to 18 years old.
  • 3\. Active lower\-limb joint arthritis involvement.
  • 4\. No previous use of foot orthoses, or previous failure of foot orthotic management, where the patient has not worn any FOs for a period of at least 3 months.
  • 5\. Ability to walk a minimum of 15 meters without assistive devices.
  • 6\. If DMARD and/or Biological therapy are used, not having started these drug therapies within 6 months of enrolling in the trial.

Exclusion Criteria

  • 1\. Inability to walk barefoot or shod.
  • 2\. Concomitant musculoskeletal disease, central or peripheral nerve disease and endocrine disorders, including Diabetes Mellitus.
  • 3\. History of lower limb surgery that required general anaesthetic.
  • 4\. Currently using FOs.
  • 5\. Where prescription of FOs is contraindicated: for example, less than 12 degrees at sub\-talar joint (STJ) range of motion; fully compensated ankle equinus; significant osseous abnormalities noted in the lower limbs and/or vertebrae during the physical evaluation. Unwillingness to wear appropriate footwear for fitting orthoses.

Outcomes

Primary Outcomes

Not specified

Similar Trials